Tigermed on Bioeconhttps://en.bioecon.ru/companies/tigermed/Recent content in Tigermed on BioeconHugoen-USSat, 25 Jul 2026 22:12:11 +0700Named-patient programs & compassionate usehttps://en.bioecon.ru/technology/named-patient-compassionate-use/Sun, 28 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/named-patient-compassionate-use/Regulated pre-approval access to investigational biopharmaceuticals for patients with serious or life-threatening disease and no satisfactory alternative — operated as a managed-access service spanning eligibility, regulatory submission, GMP drug sourcing and pharmacovigilance.CMC regulatory consulting (BLA/MAA)https://en.bioecon.ru/technology/cmc-regulatory-consulting/Wed, 24 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/cmc-regulatory-consulting/Specialized strategic advisory services guiding biopharma through the complex Chemistry, Manufacturing, and Controls (CMC) requirements to successfully file Biologics License Applications (BLA) and Marketing Authorisation Applications (MAA).